文献
J-GLOBAL ID:201902255641655492
整理番号:19A1564438
長期評価のためのMCRPC集団における非介入安全性研究におけるReassure(ラジウム-223アルファエミッター剤)の中間分析:日常臨床診療における化学療法の事前使用による患者特性と安全性【JST・京大機械翻訳】
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice
著者 (13件):
Dizdarevic Sabina
(Department of Imaging and Nuclear Medicine, Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK)
,
Dizdarevic Sabina
(Brighton and Sussex Medical School, University of Brighton and Sussex, Brighton, UK)
,
Petersen Peter Meidahl
(Rigshospitalet, Copenhagen, Denmark)
,
Essler Markus
(Universitaetsklinikum Bonn, Bonn, Germany)
,
Versari Annibale
(Azienda Unita Sanitaria Locale - IRCCS di, Reggio Emilia, Italy)
,
Bourre Jean-Cyril
(Centre Hospitalier Metropole Savoie, Chambery, France)
,
Fougere Christian
(Universitaetsklinikum Tuebingen, Tuebingen, Germany)
,
Valdagni Riccardo
(Universita degli Studi di Milano and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
,
Paganelli Giovanni
(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy)
,
Ezziddin Samer
(Universitaetsklinikum des Saarlandes, Homburg, Germany)
,
Kalinovsky Jan
(Bayer, Basel, Switzerland)
,
Bayh Inga
(Bayer AG, Wuppertal, Germany)
,
Du Yong
(Royal Marsden Hospital, London, UK)
資料名:
European Journal of Nuclear Medicine and Molecular Imaging
(European Journal of Nuclear Medicine and Molecular Imaging)
巻:
46
号:
5
ページ:
1102-1110
発行年:
2019年
JST資料番号:
A1009A
ISSN:
1619-7070
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)